Conviction
1 → 3
Conviction●●●○○3 of 5
Research target$86.41Snapshot target
Thesis statusINTACTLast reviewed 7/8/26
Market cap$11.00BSnapshot value
Research history
See all TECH changes ↗What changed
Target
— → $86.41
Thesis status
NEEDS_MORE_DATA → INTACT
Last reviewed
Not reviewed → 7/8/26
Target
— → $86.41
Reagents + instruments + bioprocessing services. Straddles Measure (reagents/instruments) and Manufacture (bioprocessing consumables). Recurring consumable pull.
Bioprocess cycle recovery; biopharma R&D spending; GMP-grade reagent demand for manufacturing.
Multi-layer exposure means neither pure-play premium nor full diversification benefit; bioprocess cyclicality; smaller scale vs TMO/DHR.
needs X/Reddit sentiment sweep
Snapshot · 7/8/26🟢 Lean-Bull · ins-$0.4M · 13F 16+/9- · short↓0.07
Snapshot · 7/8/26